Literature DB >> 23190103

KIF14 as an oncogene in retinoblastoma: a target for novel therapeutics?

Halesha D Basavarajappa1, Timothy W Corson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23190103     DOI: 10.4155/fmc.12.158

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  5 in total

1.  Kif14 overexpression accelerates murine retinoblastoma development.

Authors:  Michael O'Hare; Mehdi Shadmand; Rania S Sulaiman; Kamakshi Sishtla; Toshiaki Sakisaka; Timothy W Corson
Journal:  Int J Cancer       Date:  2016-06-24       Impact factor: 7.396

2.  KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.

Authors:  Stina M Singel; Crystal Cornelius; Elma Zaganjor; Kimberly Batten; Venetia R Sarode; Dennis L Buckley; Yan Peng; George B John; Hsiao C Li; Navid Sadeghi; Woodring E Wright; Lawrence Lum; Timothy W Corson; Jerry W Shay
Journal:  Neoplasia       Date:  2014-03       Impact factor: 5.715

Review 3.  The genomic landscape of retinoblastoma: a review.

Authors:  Brigitte L Thériault; Helen Dimaras; Brenda L Gallie; Timothy W Corson
Journal:  Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 4.207

4.  Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma.

Authors:  Andrea A Wenzel; Michael N O'Hare; Mehdi Shadmand; Timothy W Corson
Journal:  Mol Vis       Date:  2015-05-01       Impact factor: 2.367

5.  Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14.

Authors:  Kamakshi Sishtla; Natalie Pitt; Mehdi Shadmand; Michael N O'Hare; Rania S Sulaiman; Anthony L Sinn; Keith Condon; Karen E Pollok; George E Sandusky; Timothy W Corson
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.